Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person EEF1G(1-343)-ALK(1106-1620) fusion [cytosol]

Class:Id	EntityWithAccessionedSequence:9710839
_displayName	EEF1G(1-343)-ALK(1106-1620) fusion [cytosol]
_timestamp	2021-01-05 18:52:33
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9710843] Rothfels, Karen, 2021-01-05
disease	[Disease:9699595] anaplastic large cell lymphoma
endCoordinate	343
hasModifiedResidue	[FragmentInsertionModification:9710836] Insertion of residues 1106 to 1620 at 344 from UniProt:Q9UM73 ALK
literatureReference	[LiteratureReference:9710762] Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
name	EEF1G(1-343)-ALK(1106-1620) fusion Elongation factor 1-gamma EF1G_HUMAN
referenceEntity	[ReferenceGeneProduct:54174] UniProt:P26641 EEF1G [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9710859] R-HSA-9710839.1
startCoordinate	2
(hasCandidate)	[CandidateSet:9700080] ALK fusion proteins [cytosol] [Homo sapiens]
(hasComponent)	[Complex:9710891] EEF1G(1-343)-ALK(1106-1620) fusion dimer [cytosol] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by EEF1G(1-343)-ALK(1106-1620) fusion [cytosol] (9710839)